The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
1 | 12,718 | 14,056 | 29,974 |
|
United States | Bristol-Myers Squibb Co. |
Others
drug discovery | |
70 | 39 | 0.557 | 319 | 150 | 0.470 | 27,871 | 12,767 | 0.458 |
5 | 48,252 | 54,504 | 140,155 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
39 | 28 | 0.718 | 89 | 55 | 0.618 | 23,073 | 10,434 | 0.452 |
6 | 52,764 | 59,636 | 156,042 |
|
United States | Bristol-Myers Squibb Co. |
Others
Medicine | |
37 | 28 | 0.757 | 163 | 87 | 0.534 | 9,165 | 6,764 | 0.738 |
7 | 54,153 | 61,221 | 161,041 |
|
United States | Bristol-Myers Squibb Co. |
Others
Drug Discovery | |
37 | 18 | 0.486 | 67 | 26 | 0.388 | 6,559 | 1,742 | 0.266 |
14 | 68,894 | 77,975 | 214,722 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
32 | 18 | 0.563 | 65 | 33 | 0.508 | 3,500 | 972 | 0.278 |
19 | 80,838 | 91,518 | 259,751 |
|
United States | Bristol-Myers Squibb Co. |
Others
Director / Technical Development (Rare Disease) | |
29 | 13 | 0.448 | 43 | 21 | 0.488 | 2,401 | 512 | 0.213 |
22 | 83,172 | 94,153 | 268,713 |
|
United States | Bristol-Myers Squibb Co. |
Others
Drug Discovery | |
28 | 21 | 0.750 | 46 | 31 | 0.674 | 3,334 | 2,066 | 0.620 |
23 | 85,141 | 96,394 | 276,362 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
28 | 12 | 0.429 | 43 | 16 | 0.372 | 2,318 | 542 | 0.234 |
33 | 94,497 | 106,983 | 313,395 |
|
United States | Bristol-Myers Squibb Co. |
Others
Drug Discovery Chemistry | |
26 | 12 | 0.462 | 51 | 15 | 0.294 | 2,160 | 426 | 0.197 |
34 | 95,776 | 108,415 | 318,041 |
|
United States | Bristol-Myers Squibb Co. |
Others
Leads Discovery and Optimization | |
25 | 23 | 0.920 | 33 | 32 | 0.970 | 2,350 | 2,169 | 0.923 |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
35 | 99,605 | 112,771 | 333,548 |
|
United States | Bristol-Myers Squibb Co. |
Others
Raman | |
25 | 13 | 0.520 | 43 | 20 | 0.465 | 2,093 | 572 | 0.273 |
36 | 99,741 | 112,928 | 333,983 |
|
United States | Bristol-Myers Squibb Co. |
Others
Drug discovery and development | |
25 | 12 | 0.480 | 53 | 16 | 0.302 | 2,563 | 470 | 0.183 |
37 | 99,811 | 113,007 | 334,236 |
|
United States | Bristol-Myers Squibb Co. |
Others
clinical trial | statistical genetics | biomarker | design of experiment | |
25 | 12 | 0.480 | 36 | 14 | 0.389 | 4,031 | 1,090 | 0.270 |
39 | 104,938 | 118,754 | 354,064 |
|
United States | Bristol-Myers Squibb Co. |
Others
Solution NMR | |
24 | 15 | 0.625 | 26 | 20 | 0.769 | 1,957 | 581 | 0.297 |
42 | 109,760 | 124,152 | 372,931 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
23 | 17 | 0.739 | 32 | 21 | 0.656 | 4,439 | 1,972 | 0.444 |
43 | 109,910 | 124,324 | 373,362 |
|
United States | Bristol-Myers Squibb Co. |
Others
Medical Imaging | |
23 | 17 | 0.739 | 28 | 18 | 0.643 | 3,459 | 1,354 | 0.391 |
44 | 110,551 | 125,048 | 376,465 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
23 | 15 | 0.652 | 40 | 20 | 0.500 | 1,999 | 739 | 0.370 |
49 | 116,297 | 131,514 | 398,771 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
22 | 16 | 0.727 | 39 | 27 | 0.692 | 1,476 | 661 | 0.448 |
50 | 116,581 | 131,838 | 399,920 |
|
United States | Bristol-Myers Squibb Co. |
Others
Drug Development | Immune-mediated diseases | Rheumatology | |
22 | 16 | 0.727 | 29 | 23 | 0.793 | 2,000 | 907 | 0.454 |
52 | 117,473 | 132,856 | 403,884 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
22 | 14 | 0.636 | 32 | 18 | 0.563 | 1,408 | 471 | 0.335 |
54 | 121,994 | 137,874 | 420,243 |
|
United States | Bristol-Myers Squibb Co. |
Others
Drug discovery | |
21 | 18 | 0.857 | 24 | 20 | 0.833 | 4,477 | 2,263 | 0.505 |
55 | 122,766 | 138,728 | 423,407 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
21 | 17 | 0.810 | 25 | 23 | 0.920 | 5,205 | 3,114 | 0.598 |
56 | 123,064 | 139,064 | 424,901 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
21 | 16 | 0.762 | 35 | 21 | 0.600 | 1,620 | 680 | 0.420 |
59 | 125,477 | 141,807 | 434,963 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
21 | 12 | 0.571 | 25 | 14 | 0.560 | 9,536 | 5,246 | 0.550 |
61 | 126,079 | 142,462 | 437,126 |
|
United States | Bristol-Myers Squibb Co. |
Others
|
21 | 9 | 0.429 | 26 | 9 | 0.346 | 2,270 | 382 | 0.168 |